PML

Alpha Helix Corporate Finance is delighted to announce the successful completion of the sale of Physiological Measurements Limited (PML) to Citrine Diagnostics. This transaction represents a significant achievement for PML, an innovative provider of non-invasive diagnostic services, primarily community-based cardiology and ultrasound services.

We were engaged by PML to identify a strategic partner that would not only recognize the inherent value of their platform but also provide the resources for accelerated growth. Citrine Diagnostics is backed by Longacre Capital, and is a sister company of their portfolio company Inuvi, which has recently expanded its capabilities in outsourced diagnostic services through the acquisition of Express Diagnostics. This strategic move allows Citrine to offer a more comprehensive suite of services and creates exciting opportunities for PML.

Alpha Helix’s role encompassed a comprehensive sell-side advisory process, including:

• Strategic Positioning: Articulating PML's unique value proposition and market potential.

• Targeted Buyer Identification: Identifying and engaging with strategic acquirers with the optimal fit.

• Deal Structuring and Negotiation: Securing a transaction that maximized value for PML's shareholders.

• Due Diligence Management: Facilitating a smooth and efficient due diligence process.

This transaction underscores Alpha Helix's expertise in delivering successful M&A outcomes within the independent healthcare sector. We are proud to have facilitated this strategic partnership, which will enable PML to continue its expansion and providing the highest quality care for patients.

Jon Pither, Co-founder of PML commented: "Thank you Sam and the team at Alpha Helix for everything, it was a challenging process but we are delighted with the result and we wouldn't have been able to do it without you."

Sam Rolls, Director at AHCF commented "We’ve thoroughly enjoyed collaborating with Jon and Andy and are immensely proud to have facilitated this strategic partnership. We are confident that this merger will unlock significant growth potential and enable the combined business to continue to provide the best possible services to its patients."